Discover open access scientific publications

Search, annotate, share and cite publications

Publications by C. Rodriguez-Bernal

Pcv19 - Patterns of Anticoagulation Control and Clinical Outcomes in Atrial Fibrillation Patients Treated With Vitamin K Antagonists: A Real-World Study Using Population-Based Data and Group-Based Trajectory Models

Value in Health

English

Pcv115 - Quality of Inr Control and Switching to Doac Between Women and Men With Atrial Fibrillation Treated With Vitamin K Antagonists in Spain. A Population-Based, Real-World Study.

English

Related publications

Quality of INR Control and Switching to Non-Vitamin K Oral Anticoagulants Between Women and Men With Atrial Fibrillation Treated With Vitamin K Antagonists in Spain. A Population-Based, Real-World Study

PLoS ONE

Multidisciplinary

2019

English

Long-Term Vitamin K Antagonists Treatment Patterns of Non-Valvular Atrial Fibrillation (NVAF): A Population-Based Cohort Study

BMC Cardiovascular Disorders

Cardiovascular Medicine

Cardiology

2016

English

Patient Characteristics and Bleeding Events in Nonvalvular Atrial Fibrillation Patients Treated With Apixaban or Vitamin K Antagonists: Real-World Evidence From Italian Administrative Databases

Journal of Comparative Effectiveness Research

Health Policy

2018

English

Outcomes in a Warfarin-Treated Population With Atrial Fibrillation

JAMA Cardiology

Cardiovascular Medicine

Cardiology

2016

English

Clinical Outcomes and Cost-Effectiveness of Novel Oral Anticoagulants Incorporating Real-World Elderly Patients With Atrial Fibrillation

English

Prm20 - Clinical Effectiveness and Safety of Standard-Dose and Low-Dose Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation: A Nationwide Population-Based Cohort Study

English

Exposure to Vitamin K Antagonists and Kidney Function Decline in Patients With Atrial Fibrillation and Chronic Kidney Disease

Research and Practice in Thrombosis and Haemostasis

2019

English

Pcv79 - Real-World Cost-Effectiveness of Rivaroxaban Compared With Vitamin K Antagonists in the Context of Stroke Prevention in Atrial Fibrillation in France

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by C. Rodriguez-Bernal

Pcv19 - Patterns of Anticoagulation Control and Clinical Outcomes in Atrial Fibrillation Patients Treated With Vitamin K Antagonists: A Real-World Study Using Population-Based Data and Group-Based Trajectory Models

Pcv115 - Quality of Inr Control and Switching to Doac Between Women and Men With Atrial Fibrillation Treated With Vitamin K Antagonists in Spain. A Population-Based, Real-World Study.

Related publications

Quality of INR Control and Switching to Non-Vitamin K Oral Anticoagulants Between Women and Men With Atrial Fibrillation Treated With Vitamin K Antagonists in Spain. A Population-Based, Real-World Study

Long-Term Vitamin K Antagonists Treatment Patterns of Non-Valvular Atrial Fibrillation (NVAF): A Population-Based Cohort Study

Patient Characteristics and Bleeding Events in Nonvalvular Atrial Fibrillation Patients Treated With Apixaban or Vitamin K Antagonists: Real-World Evidence From Italian Administrative Databases

Outcomes in a Warfarin-Treated Population With Atrial Fibrillation

Clinical Outcomes and Cost-Effectiveness of Novel Oral Anticoagulants Incorporating Real-World Elderly Patients With Atrial Fibrillation

Prm20 - Clinical Effectiveness and Safety of Standard-Dose and Low-Dose Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation: A Nationwide Population-Based Cohort Study

Exposure to Vitamin K Antagonists and Kidney Function Decline in Patients With Atrial Fibrillation and Chronic Kidney Disease

Pcv79 - Real-World Cost-Effectiveness of Rivaroxaban Compared With Vitamin K Antagonists in the Context of Stroke Prevention in Atrial Fibrillation in France